DataMeds AI, Inc.
MEDS- Exchange
- Nasdaq
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- SEC CIK
- 0002030763
No open-market purchases or sales by DataMeds AI, Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $160.6K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by DataMeds AI, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for DataMeds AI, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Ajjarapu Surendra K | Director | 257,645 | Jun 25, 2026 | 2 |
| Patel Prashant | Chief Executive Officer | 282,365 | Jun 25, 2026 | 2 |
| Peterson Michael L | Director | 200,000 | Jul 8, 2025 | 0 |
| Shanahan Rebecca M | Director | 244,720 | Mar 25, 2025 | 0 |
| Anderson Donald William | Director | 244,720 | Mar 25, 2025 | 0 |
| Syed Sajid | Director | 244,720 | Mar 25, 2025 | 0 |
| Pirani Shafaat | Chief Clinical Officer | 102,080 | Mar 25, 2025 | 0 |
| Norton Brian | Chief Executive Officer | 9,044,720 | Mar 25, 2025 | 0 |
| Panchal Nikul | Chief Pharmacy Officer | 90,000Indirect | Mar 25, 2025 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.